Return to News Releases

SPHERICS, INC. APPOINTS AVINASH NANGIA, PhD
AS VICE PRESIDENT OF RESEARCH AND DEVELOPMENT

Lincoln, RI, June 7, 2004 - Spherics, Inc., a developer of bioadhesive-based oral drug delivery systems, today announced the appointment of Avinash Nangia, PhD as Vice President of Research and Development. Dr. Nangia has more than 13 years of drug delivery experience, successfully taking numerous drugs from development to market, while holding research management positions at Alza Corporation, Glaxo Canada, Inc., and most recently at Andrx Pharmaceuticals, Inc., where he served as Director of Research and Development.

“We are delighted to have Avinash, who brings to Spherics a great track record in applying oral drug delivery technologies to formulate and develop successful products. He was instrumental in the development of Procise™ technology at Glaxo and a number of products, including Ditropan™ XL at Alza, and Altocor™ and Fortamet™ at Andrx,” said Ze’ev Shaked, PhD, President and Chief Executive Officer of Spherics. “This key hire reflects the strong growth of our company and is in line with our R&D strategy to develop super generics based on our bioadhesive oral delivery technologies.”

Prior to joining Spherics, Dr. Nangia was Director of Research and Development at Andrx, where he was responsible for new technology development and ANDA/NDA development from preclinical development through Phase IV product support. While at Alza, Dr. Nangia served as Research Fellow and Manager in Oral Product Development Group. At Glaxo, he was Group Leader for Pharmaceutical Research and Senior Research Scientist for Intramural Basic Research.

Dr. Nangia holds a PhD in Pharmaceutics at the University of Otago, New Zealand, and a M.S. degree in Pharmaceutics at the Institute of Technology, BHU, India and a B.S. degree in Pharmacy at the University of Delhi, India.

About Spherics
Spherics is an advanced drug delivery company focused on the application of its proprietary bioadhesive technologies to enable or significantly improve the non-invasive delivery of small molecule drugs and biopharmaceuticals. The company is located in Lincoln, RI. For more information go to www.spherics.com.